Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Biologic Reports Financial Results for the Second Quarter of 2017 2017-08-03 05:00
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb® 2017-08-02 19:00
First Human Subject Enrolled in Lumosa Therapeutics' Phase 1 Trial for LT3001, a New Drug Molecule for Acute Ischemic Stroke 2017-08-01 09:46
Ortho Clinical Diagnostics Announces Global Agreement to Make B.R.A.H.M.S PCT Assay Available to Ortho Customers 2017-07-31 19:30
LEO Pharma Ranks Second in Global Clinical Trials Transparency Audit 2017-07-27 22:28
ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings 2017-07-25 21:34
Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody 2017-07-25 19:50
Strong Demand from Biopharma Industry Will Hasten NGS Informatics Providers to Boost Customized Solutions 2017-07-25 15:00
U.S. FDA Determines Celliant (R) Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products 2017-07-25 12:00
Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompe Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy 2017-07-24 14:39
Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompé Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy 2017-07-21 04:11
China Biologic Products to Report Second Quarter of 2017 Financial Results 2017-07-19 20:00
Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute 2017-07-18 18:30
CROMSOURCE Celebrates Its 20th Anniversary 2017-07-18 09:00
China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration 2017-07-17 20:50
BookDoc-MIMS: Reliable Healthcare Development on-time and Anywhere 2017-07-17 08:00
Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology 2017-07-12 23:00
The Fitzpatrick Company and Quadro Engineering Corp. Continue to Be a Leading Innovator in Powder Processing With the Scalable Lab System Milling Platform 2017-07-12 19:00
Accera Enters into a Strategic Partnership and Exclusive Licensing Agreement with DuChemBio for Accera's Technology in Korea 2017-07-11 22:00
The U.S. Food & Drug Administration Approves Endari™ (L-glutamine oral powder), the First and Only Treatment for Sickle Cell Disease in Pediatric Patients and First in Nearly 20 Years for Adults 2017-07-10 08:15
1 371 372 373 374 375 412